Sort
15,273 grants matching “antimicrobial resistance”
Fragment Size-Based Pathogen Enrichment in cfDNA
$233,250Alexander L Greninger · University Of Washington · R21 · FY2021 · AI
Planning the utilization of human challenge with Neisseria gonorrhoeae for vaccine testing
$233,250Joseph A Duncan · Univ Of North Carolina Chapel Hill · R34 · FY2020 · AI
Novel Injectable Biomaterials for Periodontitis
$233,250Hongli Sun · University Of Iowa · R21 · FY2024 · DE
Nitroimidazole susceptibility and mechanisms of resistance in Mycoplasma genitalium
$233,250Gwendolyn Wood · University Of Washington · R21 · FY2024 · AI
Statistical pangenomics to study the effects of zoonotic exposure on the gut microbiome
$233,250Amy D Willis · University Of Washington · R21 · FY2022 · AI
Novel Bacteroides fragilis Competition Factor in Carbapenem-Resistant Strains
$233,250Juliane Bubeck Wardenburg · Washington University · R21 · FY2024 · AI
Structure/function studies of biofilm agents from Aa
$233,250Univ Of Med/Dent Of Nj-Nj Dental School · R01 · FY2005 · DE
Antigenic variation of Mycoplasma genitalium during persistent genital tract infection of pig-tailed macaques
$233,250Gwendolyn Wood · University Of Washington · R21 · FY2022 · AI
Microbial Genomics Biomedical Core
$233,244Anne-Catrin Uhlemann · Columbia University Health Sciences · U54 · FY2024 · DK
GENE EXPRESSION OF P AERUGINOSA DURING BIOFILM DEVELOPME
$233,210Montana State University (Bozeman) · R01 · FY2004 · AI
Real-time estimation of antibiotic concentration in a bacterial cell
$233,160Ramesh Jha · Los Alamos Nat Secty-Los Alamos Nat Lab · R21 · FY2017 · AI
Resistance Selection Potential of the Long Acting Lipoglycopeptides Dalbavancin and Oritavancin
$233,125Brian James Werth · University Of Washington · R21 · FY2018 · AI
Immature myeloid cells as targets for therapeutics to bacterial infection
$233,113Adrianus Wilhelmus Maria Van Der Velden · State University New York Stony Brook · R21 · FY2012 · AI
Impact of Hurricane Harvey on the Maternal and Infant Microbiome and Birth Outcomes
$233,070Kjersti Marie Aagaard-Tillery · Baylor College Of Medicine · R21 · FY2018 · ES
A Novel Therapeutic Agent for the Treatment of Gram-positive Infections
$233,066James Leif Smith · Sano Chemicals, Inc · R41 · FY2020 · AI
Interferons in Neurobrucellosis
$233,055Mostafa F Ateya · University Of Missouri-Columbia · R21 · FY2024 · AI
Remodeling of Lymph Node-Derived Cytokine Responses at the Infected Tissue Site
$232,934Deborah J Fowell · Cornell University · R01 · FY2020 · AI
Microbial Genomics Biomedical Core
$232,927Anne-Catrin Uhlemann · Columbia University Health Sciences · U54 · FY2023 · DK
Microbial Genomics Biomedical Core
$232,927Anne-Catrin Uhlemann · Columbia University Health Sciences · U54 · FY2022 · DK
Molecular basis of Wnt activation by Ehrlichia Wnt ligand mimics
$232,922Jere W McBride · University Of Texas Med Br Galveston · R21 · FY2020 · AI
Rechargeable Antimicrobial Textiles to Reduce Occupational Risk of Healthcare Personnel
$232,868Yuyu Sun · University Of Massachusetts Lowell · R21 · FY2019 · OH
Epidemiology of Infectious Diseases
$232,823George R Seage · Harvard School Of Public Health · T32 · FY2018 · AI
Role of Sts-1 and -2 in the host response to bacterial pathogens
$232,781Nicholas A Carpino · State University New York Stony Brook · R21 · FY2019 · AI
Targeting transcription-coupled DNA supercoiling for discovering antibiotics against bacterial DNA gyrase
$232,576Fenfei Leng · Florida International University · R21 · FY2017 · AI
Mechanisms of ceftazidime-avibactam susceptibility and resistance among Enterobacteriaceae expressing variant KPCs
$232,558Cornelius J Clancy · University Of Pittsburgh At Pittsburgh · R21 · FY2019 · AI